Clinical oral investigations · 2025
Effects of non-surgical periodontal therapy on gingival crevicular fluid CTRP-1, TNF-α, and IL-10 levels.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kadayıf Asena, Taşçi Özge Elif, Karaduman Burcu
Аннотация
OBJECTIVES: This study investigated the gingival crevicular fluid (GCF) levels of complement-C1q tumor necrosis factor related protein-1 (CTRP-1), tumor necrosis factor-α (TNF-α), and interleukin-10 (IL-10) following non-surgical periodontal therapy (NSPT) in systemically healthy individuals with periodontal health (H), generalized gingivitis (G), and stage III grade B periodontitis (P). Moreover, this study aimed to investigate their diagnostic potential in distinguishing different periodontal diseases.
MATERIALS AND METHODS: 73 systemically healthy non-smoking individuals were divided into H (n = 25), G (n = 23) and P (n = 25) groups. Clinical periodontal parameters were recorded, and GCF samples were collected at baseline in all groups, and 3rd month after NSPT in the G and P groups. GCF levels of CTRP-1, TNF-α, and IL-10 were analyzed using ELISA. The area under the curve (AUC) was assessed using the receiver operating characteristic curve analysis.
RESULTS: CTRP-1 levels were significantly elevated in the G and P group compared to the H group (p < 0.001), while there was no significant difference between the G and P groups (p = 0.095). TNF-α and IL-10 levels were significantly higher in the P group compared to the other groups (p < 0.001). GCF CTRP-1 demonstrated an excellent diagnostic performance to discriminate periodontitis and gingivitis from periodontal health (AUC value of 0.998 and 0.974 with 100% and 91.3% sensitivity).
CONCLUSION: CTRP-1 could serve as a potential biomarker for periodontal diseases. CTRP-1 demonstrated excellent diagnostic performance in distinguishing stage III grade B periodontitis and gingivitis from periodontal health.
CLINICAL RELEVANCE: GCF CTRP-1 levels may serve as a valuable marker for diagnosing periodontal diseases.
MATERIALS AND METHODS: 73 systemically healthy non-smoking individuals were divided into H (n = 25), G (n = 23) and P (n = 25) groups. Clinical periodontal parameters were recorded, and GCF samples were collected at baseline in all groups, and 3rd month after NSPT in the G and P groups. GCF levels of CTRP-1, TNF-α, and IL-10 were analyzed using ELISA. The area under the curve (AUC) was assessed using the receiver operating characteristic curve analysis.
RESULTS: CTRP-1 levels were significantly elevated in the G and P group compared to the H group (p < 0.001), while there was no significant difference between the G and P groups (p = 0.095). TNF-α and IL-10 levels were significantly higher in the P group compared to the other groups (p < 0.001). GCF CTRP-1 demonstrated an excellent diagnostic performance to discriminate periodontitis and gingivitis from periodontal health (AUC value of 0.998 and 0.974 with 100% and 91.3% sensitivity).
CONCLUSION: CTRP-1 could serve as a potential biomarker for periodontal diseases. CTRP-1 demonstrated excellent diagnostic performance in distinguishing stage III grade B periodontitis and gingivitis from periodontal health.
CLINICAL RELEVANCE: GCF CTRP-1 levels may serve as a valuable marker for diagnosing periodontal diseases.